These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16982566)

  • 1. Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer.
    Djärv E; Nyman J; Baumann P; Ekberg L; Høyer M; Lax I; Lewensohn R; Levin N; Lund JA; Morhed E; Ericsson SR; Traberg A; Wittgren L; Johansson KA
    Acta Oncol; 2006; 45(7):973-7. PubMed ID: 16982566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
    Baumann P; Nyman J; Lax I; Friesland S; Hoyer M; Rehn Ericsson S; Johansson KA; Ekberg L; Morhed E; Paludan M; Wittgren L; Blomgren H; Lewensohn R
    Acta Oncol; 2006; 45(7):787-95. PubMed ID: 16982541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent.
    Brown WT; Wu X; Fayad F; Fowler JF; García S; Monterroso MI; de la Zerda A; Schwade JG
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):623-31. PubMed ID: 19682875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer.
    Arvidson NB; Mehta MP; Tomé WA
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1597-603. PubMed ID: 19028283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
    Xia T; Li H; Sun Q; Wang Y; Fan N; Yu Y; Li P; Chang JY
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):117-25. PubMed ID: 16765528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.
    Videtic GM; Stephans K; Reddy C; Gajdos S; Kolar M; Clouser E; Djemil T
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):344-9. PubMed ID: 19765913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
    Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
    Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
    Hiraoka M; Matsuo Y; Nagata Y
    Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning.
    Fritz P; Kraus HJ; Blaschke T; Mühlnickel W; Strauch K; Engel-Riedel W; Chemaissani A; Stoelben E
    Lung Cancer; 2008 May; 60(2):193-9. PubMed ID: 18045732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).
    Hof H; Muenter M; Oetzel D; Hoess A; Debus J; Herfarth K
    Cancer; 2007 Jul; 110(1):148-55. PubMed ID: 17516437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy.
    Takeda A; Kunieda E; Sanuki N; Ohashi T; Oku Y; Sudo Y; Iwashita H; Ooka Y; Aoki Y; Shigematsu N; Kubo A
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):363-9. PubMed ID: 19427552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
    Brown WT; Wu X; Amendola B; Perman M; Han H; Fayad F; Garcia S; Lewin A; Abitbol A; de la Zerda A; Schwade JG
    Cancer J; 2007; 13(2):87-94. PubMed ID: 17476136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets.
    Underberg RW; Lagerwaard FJ; Slotman BJ; Cuijpers JP; Senan S
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):554-60. PubMed ID: 15890600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
    Zimmermann FB; Geinitz H; Schill S; Thamm R; Nieder C; Schratzenstaller U; Molls M
    Acta Oncol; 2006; 45(7):796-801. PubMed ID: 16982542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?
    Paludan M; Traberg Hansen A; Petersen J; Grau C; Høyer M
    Acta Oncol; 2006; 45(7):818-22. PubMed ID: 16982545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
    van der Voort van Zyp NC; Prévost JB; Hoogeman MS; Praag J; van der Holt B; Levendag PC; van Klaveren RJ; Pattynama P; Nuyttens JJ
    Radiother Oncol; 2009 Jun; 91(3):296-300. PubMed ID: 19297048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
    Admiraal MA; Schuring D; Hurkmans CW
    Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.